학술논문
Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial
Document Type
Article
Author
Aghdami, Naser; Agüera-Morales, Eduardo; Ali, Rehiana; Allan, David; Arab, Leila; Battaglia, Mario; Berry, Isabelle; Blinkenberg, Morten; Bonetti, Bruno; Brundin, Lou; Capelli, Chiara; Castellan, Lucio; Cellerino, Maria; Cencioni, Maria Teresa; Clanet, Michel; Comi, Giancarlo; Courtman, David; Dazzi, Francesco; Fischer-Nielsen, Anne; Fernandez, Oscar; Fernandez, Victoria; Freedman, Mark S.; Furlan, Roberto; Gimona, Mario; Gualandi, Francesca; Guan, Qingdong; Iacobaeus, Ellen; Inglese, Matilde; Introna, Martino; Izquierdo, Guillermo; Karimi, Shahedeh; Laroni, Alice; Le Blanc, Katarina; Loaiza, Sandra; Mallik, Shahrukh; Marley, Stephen; Marrie, Ruth Ann; Marriot, James; Martino, Gianvito; Nabavi, Seyed Massood; Miller, David; Muraro, Paolo A.; Nicholas, Richard; Oliveri, Roberto S; Orengo, Giovanni; Palanicawande, Renuka; Pardini, Matteo; Radue, Ernst W; Ramo Tello, Cristina; Rush, Carolina; Schiavetti, Irene; Sellner, Johann; Sensebe, Luc; Soelberg Sorensen, Per; Sormani, Maria Pia; Strunk, Dirk; Szwajcer, David; Thalamas, Claire; Uccelli, Antonio; Wuerfel, Jens Thomas; Battaglia, Mario Alberto; Marriott, James; Muraro, Paolo; Radue, Ernst; Sorensen, Per Soelberg; Freedman, Mark S
Source
In The Lancet Neurology November 2021 20(11):917-929
Subject
Language
ISSN
1474-4422